Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-09-25, Stock:PFE, The news for the past five days is as follows:
2018-09-18: NEWS1: Health care ETF surges toward record in a broad sector rally.NEWS2: New Sub-group Analyses from the Tafamidis Phase 3 Transthyretin Amyloid Cardiomyopathy (ATTR-ACT) Study Presented at 2018 HFSA Annual Scientific Meeting.NEWS3: A Review of Pharma Stocks’ EPS Growth Rates.NEWS4: Watson Health Still the Key Driver for IBM’s AI Business.NEWS5: Pfizer Invites Public to View and Listen to Webcast of October 30 Conference Call with Analysts.NEWS6: Can Pfizer (PFE) Bank on Bavencio for Long-Term Growth?.NEWS7: Can Pfizer (PFE) Bank on Bavencio for Long-Term Growth?.NEWS8: Is the Options Market Predicting a Spike in Pfizer (PFE) Stock?.NEWS9: Is the Options Market Predicting a Spike in Pfizer (PFE) Stock?.NEWS10: Exploring Pharmaceutical Stocks’ Revenue Growth Rates.NEWS11: Is the Options Market Predicting a Spike in Pfizer (PFE) Stock?.NEWS12: Can Pfizer (PFE) Bank on Bavencio for Long-Term Growth?.NEWS13: Cronos Gets Bigger As It Partners With Ginkgo Bioworks.NEWS14: Cronos Gets Bigger As It Partners With Ginkgo Bioworks.NEWS15: A Look at the Dividends Paid by Pharma Stocks in 2018.NEWS16: Delstrigo, Pifeltro, and Merck’s Antiviral Therapy Portfolio.NEWS17: Pfizer Reports Addl Analyses From Tafamidis Phase 3 ATTR-ACT Study.NEWS18: Pfizer Reports Addl Analyses From Tafamidis Phase 3 ATTR-ACT Study.NEWS19: Cronos Gets Bigger As It Partners With Ginkgo Bioworks.NEWS20: Pharma Companies Avoid $3.8 Bln In Tax Per Year, Says Oxfam.NEWS21: Pharma Companies Avoid $3.8 Bln In Tax Per Year, Says Oxfam.NEWS22: Pfizer's Skin Disease Candidates Positive in Mid-Stage Study.NEWS23: Pfizer's Skin Disease Candidates Positive in Mid-Stage Study.NEWS24: Glaxo Seeks EU Approval for Two-Drug Regimen in First-Line HIV.NEWS25: Glaxo Seeks EU Approval for Two-Drug Regimen in First-Line HIV.
2018-09-19: NEWS1: J&J Files NDA for Erdafitinib in Urothelial Cancer Indication.NEWS2: J&J Files NDA for Erdafitinib in Urothelial Cancer Indication.NEWS3: Pharma Stocks: Pfizer’s Revenue Trend and 2018 Estimates.NEWS4: Today's Research Reports on Trending Tickers: GW Pharmaceuticals and Pfizer.NEWS5: Pharma Stocks in Review: A Valuation Comparison.
2018-09-20: NEWS1: [$$] Companies Stockpile Drugs, Chocolate as They Brace for ‘Hard’ Brexit.NEWS2: Merck or Pfizer: Which is the Better Large-Cap Pharma Stock?.NEWS3: Merck or Pfizer: Which is the Better Large-Cap Pharma Stock?.NEWS4: Eli Lilly Prices Animal Health Unit IPO at $24 Per Share.NEWS5: Eli Lilly Prices Animal Health Unit IPO at $24 Per Share.NEWS6: Eli Lilly Prices Animal Health Unit IPO at $24 Per Share.NEWS7: Merck or Pfizer: Which is the Better Large-Cap Pharma Stock?.NEWS8: Pharma Stocks: GlaxoSmithKline’s Revenue Trend and 2018 Estimates.NEWS9: Pharma Stocks: Allergan’s Revenue Trend and 2018 Estimates.NEWS10: Pfizer Granted FDA Breakthrough Therapy Designation for 20-Valent Pneumococcal Conjugate Vaccine for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older.NEWS11: Pharma Stocks: Merck & Co.’s Revenue Trend and 2018 Estimates.NEWS12: [$$] Companies' Brexit Challenge: Preparing for the Unknown.NEWS13: Pfizer: PF-06482077 Receives Breakthrough Therapy Designation - Quick Facts.NEWS14: Pfizer: PF-06482077 Receives Breakthrough Therapy Designation - Quick Facts.NEWS15: D-Day Nearing For Antares Pharma.NEWS16: D-Day Nearing For Antares Pharma.
2018-09-21: NEWS1: Pfizer (PFE) Gains As Market Dips: What You Should Know.NEWS2: Pfizer (PFE) Gains As Market Dips: What You Should Know.NEWS3: Pfizer (PFE) Gains As Market Dips: What You Should Know.NEWS4: IBD Stock Of The Day: Fido's Drugmaker Nears Third Breakout Of 2018.NEWS5: Pfizer's Pneumococcal Vaccine Gets Breakthrough Therapy Status.NEWS6: Pfizer's Pneumococcal Vaccine Gets Breakthrough Therapy Status.NEWS7: Pfizer&apos;s Pneumococcal Vaccine Gets Breakthrough Therapy Status.NEWS8: Dow 30 Stock Roundup: JPMorgan Ups Dividend, Disney's ESPN+ Hits 1M Paid Subscribers.NEWS9: Dow 30 Stock Roundup: JPMorgan Ups Dividend, Disney's ESPN+ Hits 1M Paid Subscribers.NEWS10: See what the IHS Markit Score report has to say about Pfizer Inc..NEWS11: Dow 30 Stock Roundup: JPMorgan Ups Dividend, Disney&apos;s ESPN+ Hits 1M Paid Subscribers.
2018-09-24: NEWS1: Asian Markets Mostly Lower Amid Cautious Trade.NEWS2: Asian Markets Mostly Lower Amid Cautious Trade.NEWS3: Australian Market Edges Higher.NEWS4: Australian Market Edges Higher.NEWS5: Why JNJ Stock Rose ~2.4% Last Week.NEWS6: AP investigation: Drug prices going up despite Trump promise.NEWS7: A Look at Johnson & Johnson’s Valuation This Month.NEWS8: What Potential Do Analysts See for JNJ Stock?.NEWS9: AP investigation: Drug prices going up despite Trump promise.NEWS10: AP review: Drug prices keep going up despite Trump pressure.NEWS11: Resurgent Pfizer Stock Testing 19-Year Resistance.NEWS12: Astellas Receives Positive CHMP Opinion for XTANDI® (enzalutamide) for Adult Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer.NEWS13: Today’s Research Reports on Stocks to Watch: Oragenics and Pfizer.NEWS14: Why Amarin Corporation Stock Is Exploding Higher Today.NEWS15: Astellas Pharma Gets Positive CHMP Opinion For Xtandi - Quick Facts.NEWS16: Astellas Pharma Gets Positive CHMP Opinion For Xtandi - Quick Facts.

Answer: Decrease